Dogs and Cats:
Treatment and prevention of flea infestations caused by Ctenocephalides spp. for one month following a single administration. This is as a result of the adulticidal, larvicidal and ovicidal properties of the product. The product is ovicidal for 3 weeks after administration. Through a reduction in the flea population, monthly treatment of pregnant and lactating animals will also aid in the prevention of flea infestations in the litter for up to seven weeks of age.
The product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in areas to which the animal has access.
Treatment of ear mites (Otodectes cynotis).
Prevention of heartworm disease caused by Dirofilaria immitis with monthly administration. The veterinary medicinal product may be safely administered to animals infected with adult heartworms, however, it is recommended in accordance with good veterinary practise, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before the administration of the veterinary medicinal product.
It is also recommended that dogs should be tested periodically for adult heartworm infections, as an integral part of a heartworm prevention strategy, even when the veterinary medicinal product has been administered monthly. This product is not effective against D. immitis.
Dogs:
Treatment of adult intestinal roundworms (Toxocara canis).
Treatment of sarcoptic mange (caused by Sarcoptes scabiei).
Treatment of biting lice infestations (Trichodectes canis).
Cats:
Treatment of adult roundworms (Toxocara cati).
Treatment of adult intestinal hookworms (Ancylostoma tubaeforme).
Treatment of biting lice infestations (caused by Felicola subrostratus).